Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / S&P BIOTECH
-
Number of holders
-
684
-
Total 13F shares, excl. options
-
78,409,946
-
Shares change
-
+7,227,991
-
Total reported value, excl. options
-
$7,048,358,412
-
Value change
-
+$613,537,361
-
Put/Call ratio
-
100%
-
Number of buys
-
345
-
Number of sells
-
292
-
Price
-
$89.88
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q1 2022
As of 31 Mar 2022 SPDR SERIES TRUST - S&P BIOTECH (XBI) had 684 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 78,409,946 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, BNP PARIBAS ARBITRAGE, SA, CITIGROUP INC, TORONTO DOMINION BANK, Avoro Capital Advisors LLC, Matrix Capital Management Company, LP, UBS Group AG, and Clal Insurance Enterprises Holdings Ltd.
This table shows 685 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.